肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

肾上腺皮质癌诊治专家共识

2021-11-15 中国医师协会泌尿外科分会 现代泌尿外科杂志

肾上腺皮质癌泌尿生殖系肿瘤

肾上腺皮质癌(adrenocortical carcinoma,ACC)是一种罕见的高度侵袭性的恶性内分泌肿瘤。

中文标题：

肾上腺皮质癌诊治专家共识

发布机构：

中国医师协会泌尿外科分会

发布日期：

2021-11-15

简要介绍：

肾上腺皮质癌(adrenocortical carcinoma,ACC)是一种罕见的高度侵袭性的恶性内分泌肿瘤。其估计发病率为0.7×106～2.0×106例/年,1～4岁和40～50岁发病多见,女性患病率较高[1-2]。ACC可能为有功能的(指具有激素分泌功能),引起库欣综合征和/或男性化;也可能为无功能的,表现为上腹部肿块或者仅偶然发现。该病预后差,5年总生存率仅15%～44%[3-4]。

相关资料下载：
[AttachmentFileName(sort=1, fileName=肾上腺皮质癌诊治专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bed151c0022901b8, title=肾上腺皮质癌诊治专家共识, enTitle=, guiderFrom=现代泌尿外科杂志, authorId=0, author=, summary=肾上腺皮质癌(adrenocortical carcinoma,ACC)是一种罕见的高度侵袭性的恶性内分泌肿瘤。, cover=https://img.medsci.cn/20211213/1639410032966_5579292.jpg, journalId=0, articlesId=null, associationId=2221, associationName=中国医师协会泌尿外科分会, associationIntro=中国医师协会泌尿外科分会, copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">肾上腺皮质癌(adrenocortical carcinoma,ACC)是一种罕见的高度侵袭性的恶性内分泌肿瘤。其估计发病率为0.7&times;106～2.0&times;106例/年,1～4岁和40～50岁发病多见,女性患病率较高[1-2]。ACC可能为有功能的(指具有激素分泌功能),引起库欣综合征和/或男性化;也可能为无功能的,表现为上腹部肿块或者仅偶然发现。该病预后差,5年总生存率仅15%～44%[3-4]。</span></p>, tagList=[TagDto(tagId=60088, tagName=肾上腺皮质癌), TagDto(tagId=117298, tagName=泌尿生殖系肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=60088, guiderKeyword=肾上腺皮质癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4238, appHits=139, showAppHits=0, pcHits=842, showPcHits=4099, likes=2, shares=14, comments=9, approvalStatus=1, publishedTime=Mon Dec 13 23:47:51 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Dec 13 23:44:09 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 07:54:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肾上腺皮质癌诊治专家共识.pdf)])
肾上腺皮质癌诊治专家共识.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2153230, encodeId=f26321532301c, content=罕见 但仍需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/bd34754d3b0046c2bd64321e47863622/81281d26ab254ed9803ad3323b1a5f2a.jpg, createdBy=0d5f1677558, createdName=毅哥, createdTime=Thu Aug 17 14:12:54 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191644, encodeId=01be1191644c7, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:46:46 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182093, encodeId=7ca61182093b8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72815515020, createdName=ms8000000272250697, createdTime=Sat Jan 08 08:26:46 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085736, encodeId=ceed1085e3615, content=学习一下，很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/e5955f8f66c74ca79054aaa1fdc6f8e9/71cd95e75dd94cc4b1d805f0bc20b9f2.jpg, createdBy=c78d6387675, createdName=小李doctor, createdTime=Thu Dec 30 09:46:29 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081376, encodeId=91ba10813e64e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:17:01 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2023-08-17 毅哥

    罕见 但仍需要学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2153230, encodeId=f26321532301c, content=罕见 但仍需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/bd34754d3b0046c2bd64321e47863622/81281d26ab254ed9803ad3323b1a5f2a.jpg, createdBy=0d5f1677558, createdName=毅哥, createdTime=Thu Aug 17 14:12:54 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191644, encodeId=01be1191644c7, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:46:46 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182093, encodeId=7ca61182093b8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72815515020, createdName=ms8000000272250697, createdTime=Sat Jan 08 08:26:46 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085736, encodeId=ceed1085e3615, content=学习一下，很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/e5955f8f66c74ca79054aaa1fdc6f8e9/71cd95e75dd94cc4b1d805f0bc20b9f2.jpg, createdBy=c78d6387675, createdName=小李doctor, createdTime=Thu Dec 30 09:46:29 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081376, encodeId=91ba10813e64e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:17:01 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2022-02-09 147f42d5m31暂无昵称

    想学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2153230, encodeId=f26321532301c, content=罕见 但仍需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/bd34754d3b0046c2bd64321e47863622/81281d26ab254ed9803ad3323b1a5f2a.jpg, createdBy=0d5f1677558, createdName=毅哥, createdTime=Thu Aug 17 14:12:54 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191644, encodeId=01be1191644c7, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:46:46 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182093, encodeId=7ca61182093b8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72815515020, createdName=ms8000000272250697, createdTime=Sat Jan 08 08:26:46 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085736, encodeId=ceed1085e3615, content=学习一下，很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/e5955f8f66c74ca79054aaa1fdc6f8e9/71cd95e75dd94cc4b1d805f0bc20b9f2.jpg, createdBy=c78d6387675, createdName=小李doctor, createdTime=Thu Dec 30 09:46:29 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081376, encodeId=91ba10813e64e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:17:01 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2022-01-08 ms8000000272250697

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2153230, encodeId=f26321532301c, content=罕见 但仍需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/bd34754d3b0046c2bd64321e47863622/81281d26ab254ed9803ad3323b1a5f2a.jpg, createdBy=0d5f1677558, createdName=毅哥, createdTime=Thu Aug 17 14:12:54 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191644, encodeId=01be1191644c7, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:46:46 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182093, encodeId=7ca61182093b8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72815515020, createdName=ms8000000272250697, createdTime=Sat Jan 08 08:26:46 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085736, encodeId=ceed1085e3615, content=学习一下，很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/e5955f8f66c74ca79054aaa1fdc6f8e9/71cd95e75dd94cc4b1d805f0bc20b9f2.jpg, createdBy=c78d6387675, createdName=小李doctor, createdTime=Thu Dec 30 09:46:29 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081376, encodeId=91ba10813e64e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:17:01 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-30 小李doctor

    学习一下，很受用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2153230, encodeId=f26321532301c, content=罕见 但仍需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210630/bd34754d3b0046c2bd64321e47863622/81281d26ab254ed9803ad3323b1a5f2a.jpg, createdBy=0d5f1677558, createdName=毅哥, createdTime=Thu Aug 17 14:12:54 CST 2023, time=2023-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191644, encodeId=01be1191644c7, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12ff5257106, createdName=147f42d5m31暂无昵称, createdTime=Wed Feb 09 23:46:46 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182093, encodeId=7ca61182093b8, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=72815515020, createdName=ms8000000272250697, createdTime=Sat Jan 08 08:26:46 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085736, encodeId=ceed1085e3615, content=学习一下，很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211206/e5955f8f66c74ca79054aaa1fdc6f8e9/71cd95e75dd94cc4b1d805f0bc20b9f2.jpg, createdBy=c78d6387675, createdName=小李doctor, createdTime=Thu Dec 30 09:46:29 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081376, encodeId=91ba10813e64e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69756410344, createdName=ms9000001816745907, createdTime=Fri Dec 17 23:17:01 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-17 ms9000001816745907

    学习

    0

相关指南

米托坦治疗肾上腺皮质癌专家共识(2021)

北京协和医院罕见病多学科协作组 · 2021-09-30

拓展阅读

米托坦治疗肾上腺皮质癌专家共识(2021)

北京协和医院罕见病多学科协作组 · 2021-09-30